Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2

被引:40
|
作者
Vokurka, S. [1 ]
Steinerova, K. [1 ]
Karas, M. [1 ]
Koza, V. [1 ]
机构
[1] Univ Hosp Plzen Pilsen, Dept Haematooncol, Plzen 30460, Pilsen, Czech Republic
关键词
oral mucositis; melphalan; stem cell transplantation; toxicity; graft-versus-host disease; VERSUS-HOST-DISEASE; HIGH-DOSE MELPHALAN; MARROW-TRANSPLANTATION; CHEMOTHERAPY; FLUDARABINE; PREVENTION; RECIPIENTS; THERAPY; MYELOMA;
D O I
10.1038/bmt.2009.66
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The fludarabine ( FLU)/melphalan (MEL) conditioning regimen containing FLU and high-dose MEL was analyzed in comparison with the BU/CY2 regimen to characterize oral mucositis ( OM) and risk factors. OM incidence significantly varied between BU/CY2 and FLU/ MEL ( 100 vs 78%, P = 0.004), but the incidence of severe OM grades 3-4 WHO and kinetics of OM were fully comparable. Patients with OM persisting on day +21 had more acute GVHD (68 vs 32%, P = 0.005), which tended to occur earlier than among those without such prolonged OM. Multivariate analysis showed significant dependency of acute GVHD on severity and prolonged duration of OM and significant correlation between OM severity and its prolonged duration. Body surface area-based dosing in the FLU/ MEL regimen led to a wide range of MEL doses administered per kilogram body weight (2.5-5.2 mg/kg, median 3.5). In multivariate analysis, MEL dose per kilogram of body weight was found to be a significant predictor of OM incidence and severity. Female gender and lower body mass index were less important variables than the fact that the actual dose of MEL administered per kilogram of body weight was relatively high when the dosage was calculated on the basis of body surface area. Bone Marrow Transplantation ( 2009) 44, 601-605; doi: 10.1038/bmt.2009.66; published online 6 April 2009
引用
收藏
页码:601 / 605
页数:5
相关论文
共 50 条
  • [21] Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Zhu, Cheng-ying
    Chen, Guo-feng
    Zhou, Wei
    Hou, Cheng
    Wang, Xiao-kai
    Wang, Fei-yan
    Yang, Nan
    Wang, Li
    Fang, Shu
    Luo, Lan
    Guan, Li-xun
    Zhang, Ran
    Liu, Yu-chen
    Dou, Li-ping
    Gao, Chun-ji
    ANNALS OF TRANSPLANTATION, 2019, 24 : 328 - 340
  • [22] Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignancies
    Bhatnagar, Bhavana
    Rapoport, Aaron P.
    Fang, Hong-Bin
    Ilyas, Can
    Marangoz, Deniz
    Akbulut, Vinil
    Ruehle, Kathleen
    Badros, Ashraf
    Yanovich, Saul
    Akpek, Goerguen
    ANNALS OF HEMATOLOGY, 2014, 93 (04) : 653 - 660
  • [23] Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma
    Batlle, Montserrat
    Morgades, Mireia
    Vives, Susana
    Ferra, Christelle
    Oriol, Albert
    Sancho, Juan-Manuel
    Xicoy, Blanca
    Moreno, Miriam
    Magallon, Laura
    Ribera, Josep-Maria
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 487 - 491
  • [24] INFECTIOUS COMPLICATIONS AND THEIR CONTRIBUTING RISK FACTORS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Akhmedov, M., I
    Klyasova, G. A.
    Parovichnikova, E. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (01): : 90 - 107
  • [25] Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation
    Aleksandra Wysocka-Słowik
    Lidia Gil
    Zuzanna Ślebioda
    Agnieszka Kręgielczak
    Barbara Dorocka-Bobkowska
    Annals of Hematology, 2021, 100 : 2079 - 2086
  • [26] Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
    Nakaseko, Chiaki
    Ozawa, Shinichi
    Sakaida, Emiko
    Sakai, Miwa
    Kanda, Yoshinobu
    Oshima, Kumi
    Kurokawa, Mineo
    Takahashi, Satoshi
    Ooi, Jun
    Shimizu, Takayuki
    Yokota, Akira
    Yoshiba, Fumiaki
    Fujimaki, Katsumichi
    Kanamori, Heiwa
    Sakai, Rika
    Saitoh, Takayuki
    Sakura, Tohru
    Maruta, Atsuo
    Sakamaki, Hisashi
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 375 - 382
  • [27] Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients
    Karin Garming Legert
    Mats Remberger
    Olle Ringdén
    Anders Heimdahl
    Göran Dahllöf
    Supportive Care in Cancer, 2014, 22 : 2133 - 2140
  • [28] Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation
    Blennow, Ola
    Remberger, Mats
    Torlen, Johan
    Szakos, Attila
    Ljungman, Per
    Mattsson, Jonas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) : 1684 - 1689
  • [29] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
  • [30] A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
    Hobbs, G. S.
    Kaur, N.
    Hilden, P.
    Ponce, D.
    Cho, C.
    Castro-Malaspina, H. R.
    Giralt, S.
    Goldberg, J. D.
    Jakubowski, A. A.
    Papadopoulos, E. B.
    Sauter, C.
    Koehne, G.
    Yahalom, J.
    Delvin, S.
    Barker, J. N.
    Perales, M-A
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 1010 - 1012